| 685358 |
LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY |
A field guide to U.S. healthcare reform: The evolution to
value‐based
healthcare |
2021-05-01 |
10.1002/lio2.575 |
Harrill Willard C., Melon David E. |
| 685357 |
JOURNAL OF OVARIAN RESEARCH |
Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation |
2021-05-01 |
10.1186/s13048-021-00815-y |
Dai Lan, Wang Chen, Song Keqi, Wang Wenjing, Di Wen |
| 685356 |
CLINICAL LUNG CANCER |
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial |
2021-05-01 |
10.1016/j.cllc.2021.05.007 |
Gadgeel Shirish, Hirsch Fred R., Kerr Keith, Barlesi Fabrice, Park Keunchil, Rittmeyer Achim, Zou Wei, Bhatia Namrata, Koeppen Hartmut, Paul Sarah M., Shames David, Yi Jing, Matheny Christina, Ballinger Marcus, McCleland Mark, Gandara David R. |
| 685355 |
CLINICAL LUNG CANCER |
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878) |
2021-05-01 |
10.1016/j.cllc.2021.05.001 |
Riess Jonathan W., Reckamp Karen L., Frankel Paul, Longmate Jeffrey, Kelly Karen A., Gandara David R., Weipert Caroline M., Raymond Victoria M., Keer Harold N., Mack Philip C., Newman Edward M., Jr. Primo N. Lara |
| 685354 |
CLINICAL LUNG CANCER |
Table of Contents |
2021-05-01 |
10.1016/s1525-7304(21)00082-6 |
|
| 685353 |
CLINICAL LUNG CANCER |
Lung adenocarcinoma with primary LIMD1-BRAF fusion treated with MEK inhibitor: a case report |
2021-05-01 |
10.1016/j.cllc.2021.05.003 |
Wang Cheng-You, Hsia Jiun-Yi, Li Che-Hsing, Ho Chao-Chi, Chao Wan-Ru, Wu Ming-Fang |
| 685352 |
CLINICAL LUNG CANCER |
EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study. | EGFR Tyrosine Kinase Inhibitor (TKI |
2021-05-01 |
10.1016/j.cllc.2020.06.005 |
Chang Qing, Xu Jianlin, Qiang Huiping, Teng Jiajun, Qian Jialin, Lv Minfang, Zhang Yanwei, Lou Yuqing, Zhao Yizhuo, Zhong Runbo, Han Baohui, Chu Tianqing |
| 685351 |
CLINICAL LUNG CANCER |
Considerations for the Surgical Management of Early Stage Lung Cancer during the COVID-19 Pandemic |
2021-05-01 |
10.1016/j.cllc.2020.06.024 |
Merritt Robert E., Kneuertz Peter J. |
| 685350 |
CLINICAL LUNG CANCER |
Utilization Trends and Factors Associated With ROS1 Testing Among Advanced Non–small-cell Lung Cancer Patients in US Community Practices |
2021-05-01 |
10.1016/j.cllc.2020.06.019 |
Wong William, Wu Ning, Gupta Ravindra, Mansfield Aaron Scott |
| 685349 |
CLINICAL LUNG CANCER |
Lung adenocarcinoma harboring concomitant EGFR mutations and BRAF V600E responds to a combination of osimertinib and vemurafenib to overcome osimertinib resistance |
2021-05-01 |
10.1016/j.cllc.2020.06.008 |
Xie Zhanhong, Gu Yingying, Xie Xiaohong, Lin Xinqing, Ouyang Ming, Qin Yinyin, Zhang Jiexia, Lizaso Analyn, Chen Shuyin, Zhou Chengzhi |
